124 related articles for article (PubMed ID: 16809183)
1. Motives for and against injecting drug use among young adults in Amsterdam: qualitative findings and considerations for disease prevention.
Witteveen E; Van Ameijden EJ; Schippers GM
Subst Use Misuse; 2006; 41(6-7):1001-16. PubMed ID: 16809183
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with the initiation of cocaine and heroin among problem drug users: reflections on interventions.
Witteveen E; van Ameijden EJ; Prins M; Schippers GM
Subst Use Misuse; 2007; 42(6):933-47. PubMed ID: 17613955
[TBL] [Abstract][Full Text] [Related]
3. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
Panda S; Sharma M
Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
[TBL] [Abstract][Full Text] [Related]
4. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
[TBL] [Abstract][Full Text] [Related]
5. Social context of needle selling in Baltimore, Maryland.
Latkin CA; Davey MA; Hua W
Subst Use Misuse; 2006; 41(6-7):901-13. PubMed ID: 16809178
[TBL] [Abstract][Full Text] [Related]
6. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
[TBL] [Abstract][Full Text] [Related]
7. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study.
Lindenburg CE; Krol A; Smit C; Buster MC; Coutinho RA; Prins M
AIDS; 2006 Aug; 20(13):1771-5. PubMed ID: 16931942
[TBL] [Abstract][Full Text] [Related]
8. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
Copeman M
Med J Aust; 2003 Jul; 179(2):119; author reply 119. PubMed ID: 12864712
[No Abstract] [Full Text] [Related]
9. Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programs.
Kuyper LM; Kerr T; Li K; Hogg RS; Tyndall MW; Montaner JS; Wood E
Subst Use Misuse; 2006; 41(6-7):883-99. PubMed ID: 16809177
[TBL] [Abstract][Full Text] [Related]
10. Street policing, injecting drug use and harm reduction in a Russian city: a qualitative study of police perspectives.
Rhodes T; Platt L; Sarang A; Vlasov A; Mikhailova L; Monaghan G
J Urban Health; 2006 Sep; 83(5):911-25. PubMed ID: 16855880
[TBL] [Abstract][Full Text] [Related]
11. Needle and syringe exchange programs in Amsterdam.
Witteveen E; Schippers G
Subst Use Misuse; 2006; 41(6-7):835-6. PubMed ID: 16809172
[No Abstract] [Full Text] [Related]
12. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
13. Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales.
Cao W; Treloar C
Drug Alcohol Rev; 2006 Sep; 25(5):439-44. PubMed ID: 16939939
[TBL] [Abstract][Full Text] [Related]
14. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
[TBL] [Abstract][Full Text] [Related]
15. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
16. Needle exchange and the HIV outbreak among injection drug users in Vancouver, Canada.
Wood E; Kerr T
Subst Use Misuse; 2006; 41(6-7):841-3. PubMed ID: 16809174
[No Abstract] [Full Text] [Related]
17. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
18. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
[TBL] [Abstract][Full Text] [Related]
20. Public injection settings in Vancouver: physical environment, social context and risk.
Small W; Rhodes T; Wood E; Kerr T
Int J Drug Policy; 2007 Jan; 18(1):27-36. PubMed ID: 17689341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
